GlassScriptPhysician profile
Al-Wala Awad
NPI 1609261759
$13,919.14
in general payments reported to CMS, 2019-2025
16 companies · $3,673 in 2025
The $3,673 reported for 2025 was more than what 77% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,312 · 2020: $918 · 2021: $494 · 2022: $3,651 · 2023: $2,478 · 2024: $1,392 · 2025: $3,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,795 · Travel and Lodging: $2,749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,795.03 |
| Travel and Lodging | $2,748.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,388.96 | 2019-2025 | Surpass Evolve, Target |
| Medtronic, INC. | $2,938.34 | 2022-2025 | Pipeline, Clydesdale Ptc Spinal System, Catalyft Pl Expandable Interbody System |
| Penumbra, INC. | $1,401.97 | 2023-2025 | Red 72, Penumbra Coil 400, Neuron |
| Depuy Synthes Sales INC. | $1,390.43 | 2019-2025 | Cerepak Uniform, N/A, Trufill |
| Silk Road Medical, INC. | $776.24 | 2022 | |
| Medtronic USA, INC. | $722.91 | 2019 | |
| Microvention, INC. | $429.28 | 2020-2023 | Stent, Web Aneurysm Embolization System |
| Zimmer Biomet Holdings, INC. | $395.11 | 2020-2021 | |
| Boston Scientific Corporation | $308.97 | 2019-2024 | |
| Integra Lifesciences Corporation | $291.61 | 2019-2022 | |
| Alphatec Spine, INC | $242.87 | 2024 | Other - Miscellaneous |
| Balt USA, LLC | $219.35 | 2023 | Optima Coil System |
| Orthofix Medical, INC. | $181.82 | 2023-2025 | Lattus, Newbridge, M6-C |
| Si-Bone, INC. | $113.46 | 2019 | |
| Aesculap, INC. | $104.30 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Al-Wala Awad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.